Clinical Trial Update: Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial studied docetaxel and cisplatin with or without dimesna in stage IIIB/IV non-small cell lung cancer and has completed; adverse events of inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Dimesna (dimesna)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anemia, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Status: COMPLETED